tiprankstipranks
Xinyang Maojian Group Limited (HK:0362)
:0362
Hong Kong Market

Xinyang Maojian Group (0362) AI Stock Analysis

2 Followers

Top Page

HK:0362

Xinyang Maojian Group

(0362)

Select Model
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.01
▼(-30.00% Downside)
Action:N/ADate:07/25/25
The overall stock score of 43 reflects significant concerns, primarily driven by extremely weak financial performance with declining revenue, persistent losses, negative equity, and high debt. Technical analysis indicates a long-term downtrend despite oversold conditions, and valuation remains uncertain due to negative earnings. Financial health is the most critical factor dragging down the score.
Positive Factors
Market Position
The company's specialization in Xinyang Maojian tea, a renowned variety, positions it well in the niche market for high-quality tea, potentially attracting loyal consumers and differentiating it from competitors.
Negative Factors
Revenue Decline
A consistent decline in revenue indicates challenges in maintaining market share and competitiveness, which can impact long-term growth prospects and financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Market Position
The company's specialization in Xinyang Maojian tea, a renowned variety, positions it well in the niche market for high-quality tea, potentially attracting loyal consumers and differentiating it from competitors.
Read all positive factors

Xinyang Maojian Group (0362) vs. iShares MSCI Hong Kong ETF (EWH)

Xinyang Maojian Group Business Overview & Revenue Model

Company Description
China Zenith Chemical Group Limited, an investment holding company, generates and supplies heat and power in the People's Republic of China. It operates through three segments: Heat and Power, Calcium Carbide, and Construction Service. The company...
How the Company Makes Money
Xinyang Maojian Group generates revenue through the sale of its tea products, which include both loose leaf and packaged tea varieties. The company leverages its extensive supply chain and distribution network to reach a wide range of customers, f...

Xinyang Maojian Group Financial Statement Overview

Summary
Financial performance is critically weak with a drastic revenue decline of 68.7% to 31.6M in 2024, persistent net losses (net profit margin of -514.9%), negative equity (-1.01B), and high debt (1.17B). While there are minor improvements in gross margin and cash flow outflows, the overall financial health indicates severe operational and structural challenges.
Income Statement
15
Very Negative
Balance Sheet
10
Very Negative
Cash Flow
20
Very Negative
BreakdownTTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income Statement
Total Revenue28.35M31.56M100.85M198.66M229.02M194.34M
Gross Profit-12.81M11.15M-5.10M32.48M-25.57M-61.06M
EBITDA-31.45M-39.20M-9.27M-30.19M-162.54M-175.57M
Net Income-144.45M-162.50M-155.88M-1.06B-450.35M-354.89M
Balance Sheet
Total Assets380.92M478.10M666.63M1.24B2.07B1.93B
Cash, Cash Equivalents and Short-Term Investments1.19M30.76M3.01M14.85M47.34M8.82M
Total Debt1.12B1.17B1.17B1.26B1.26B1.13B
Total Liabilities1.46B1.49B1.61B2.06B1.98B1.57B
Stockholders Equity-1.08B-1.01B-955.36M-873.17M29.56M302.56M
Cash Flow
Free Cash Flow-18.44M-8.02M-20.77M-69.92M-76.85M-16.58M
Operating Cash Flow-17.26M-5.25M-12.76M-26.69M-58.09M3.08M
Investing Cash Flow74.23M642.00K-8.42M-34.15M-27.64M-26.09M
Financing Cash Flow-56.67M32.44M9.59M26.09M126.99M23.98M

Xinyang Maojian Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0362, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0362.

Xinyang Maojian Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$3.75B-15.641.68%
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
60
Neutral
HK$11.49B8.625.97%6.26%2.47%-6.46%
58
Neutral
HK$1.88B16.566.80%10.94%-16.17%-31.65%
58
Neutral
HK$527.39M5.884.00%1.05%16.01%-53.67%
52
Neutral
HK$115.14M11.651.06%2.27%-1.46%834.07%
43
Neutral
HK$20.27M-0.13-15.02%88.05%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0362
Xinyang Maojian Group
0.02
0.00
0.00%
HK:0182
Concord New Energy Group
0.24
-0.16
-39.70%
HK:1798
China Datang Corp. Renewable Power Co. Ltd. Class H
1.58
-0.40
-20.29%
HK:0090
Puxing Energy Ltd.
1.15
0.66
134.69%
HK:1250
Shandong Hi-Speed New Energy Group Limited
1.67
0.07
4.37%
HK:1671
Tianjin Tianbao Energy Co., Ltd. Class H
0.72
0.22
44.00%

Xinyang Maojian Group Corporate Events

China Zenith Chemical Faces Continued Suspension and Delisting Risk as Liquidators Review Operations
Dec 22, 2025
China Zenith Chemical Group Limited, a Hong Kong-listed chemical manufacturer now in compulsory liquidation, is under the control of joint and several liquidators who are still assessing the state of its business by examining available books and r...
China Zenith Chemical Group Appoints Liquidators Amidst Operational Changes
Nov 21, 2025
China Zenith Chemical Group Limited, currently in compulsory liquidation, has appointed Osman Mohammed Arab and Lai Wing Lun as joint and several liquidators following a High Court order. The company has also announced a change in its principal pl...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 25, 2025